Emtricitabine / Tenofovir Disoproxil
Also known as: Emtricitabine-Tenofovir Disoproxil, Truvada.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 100-150 MG | Tablet | $10.19 / unit | Generic |
| 200-300 MG | Tablet | $0.457 / unit | Generic |
| 200 MG-300 MG | Tablet | $59.70 / unit | Brand |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $30,273,749 gross for Emtricitabine / Tenofovir Disoproxil across 171,063 prescriptions (measured, national).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS